Please Wait
Applying Filters...
menu
    • menu
    DRL-PSE
    News
    Dr Reddy's subsidiary sells, assigns US rights for 3 brands Encore Dermatology

    03 Apr 2019

    // ECONOMIC TIMES

    Promius promotes digital campaign to empower skin condition patients

    05 Nov 2018

    // Beth Snyder Bulik FIERCE PHARMA

    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Perrigo Uk Finco

    23 May 2018

    // PATENT LITIGATION

    DATA COMPILATION
    #PharmaFlow

    Dr Reddy Promius Pharma RM

    Contact Supplier

    Website

    IPhEB Russia

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/excipient-market-overview-clariant-sets-up-its-first-peg-excipients-facility-in-us-india-harmonizes-22-excipient-monographs
    Left Arrow
    Right Arrow
    Related CompaniesRelated Companies

    About

    Promius Pharma, LLC, is a branded pharmaceutical company that entered the dermatology market in 2008. Headquartered in Princeton, New Jersey, Promius Pharma is a wholly owned subsidiary of Dr. Reddy's Laboratories, one of India's largest and most respected pharmaceutical companies. Promius Pharma is a new face in the dermatology community and will provide fresh, innovative products and ideas that meet unmet physician and patient needs. We also differentiate our company in our reliance on research and development, in our commitment to using input from physicians to shape our focus and future direction.
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.